Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Microelectronics | | | | 336.4 | | | | |
| Life sciences | | | | 30.7 | | | | |
| Other | | | | | 26.8 | | | |
| Septem U.S. | | | | | 50.3 | | | |
| Other | | | | | 177.6 | | | |
| Total revenues | 361.0 | 365.8 | 351.8 | 367.3 | 254.7 | 339.1 | 364.1 | 325.9 |
| Revenue growth | -1.3% | 4.0% | -4.2% | 44.2% | -24.9% | -6.9% | 11.7% | 15.7% |
| Cost of goods sold | 185.0 | 179.3 | 181.1 | 191.2 | 152.5 | 172.6 | 182.5 | 162.5 |
| Gross profit | 175.9 | 186.6 | 170.7 | 176.0 | 102.2 | 166.5 | 181.6 | 163.4 |
| Gross margin | 48.7% | 51.0% | 48.5% | 47.9% | 40.1% | 49.1% | 49.9% | 50.1% |
| Selling, general and administrative | 72.9 | 73.5 | 68.7 | 85.4 | 76.4 | 88.8 | 99.2 | 90.1 |
| Research and development | 55.7 | 47.3 | 46.8 | 48.6 | 37.2 | 37.8 | 29.9 | 26.2 |
| Other operating expenses | -11.7 | -0.9 | 84.0 | -0.5 | | | | |
| EBITDA [+] | 87.9 | 94.3 | -1.6 | 69.2 | 15.5 | 64.1 | 74.3 | 67.8 |
| EBITDA growth | -6.7% | -6051.0% | -102.3% | 347.3% | -75.9% | -13.8% | 9.6% | 15.0% |
| EBITDA margin | 24.4% | 25.8% | -0.5% | 18.8% | 6.1% | 18.9% | 20.4% | 20.8% |
| Depreciation | 26.0 | 25.1 | 25.5 | 22.8 | 26.8 | 24.1 | 21.8 | 20.8 |
| EBITA | 61.9 | 69.2 | -27.1 | 46.4 | -11.3 | 39.9 | 52.5 | 47.0 |
| EBITA margin | 17.2% | 18.9% | -7.7% | 12.6% | -4.5% | 11.8% | 14.4% | 14.4% |
| Amortization of intangibles | 2.8 | 2.5 | 1.6 | 4.0 | | | | |
| EBIT [+] | 59.1 | 66.7 | -28.7 | 42.4 | -11.3 | 39.9 | 52.5 | 47.0 |
| EBIT growth | -11.4% | -332.0% | -167.7% | -474.3% | -128.4% | -24.0% | 11.7% | 16.4% |
| EBIT margin | 16.4% | 18.2% | -8.2% | 11.6% | -4.5% | 11.8% | 14.4% | 14.4% |
| Non-recurring items [+] | 11.7 | 0.9 | 0.6 | 0.5 | | | | |
| Asset impairment | 11.7 | 0.9 | 0.6 | 0.5 | | | | |
| Interest income | 0.9 | 0.9 | 1.1 | 0.9 | 1.2 | 3.1 | 7.7 | 8.4 |
| Interest income | 0.9 | 0.9 | 1.1 | 0.9 | 1.2 | 3.1 | 7.7 | 8.4 |
| Other income (expense), net [+] | 2.6 | -0.1 | -1.0 | 7.7 | -3.5 | -2.9 | -0.8 | 0.5 |
| Gain (loss) on investments | | | | | | -3.4 | | -0.3 |
| Gain (loss) on debt retirement | | | 84.6 | | | | | |
| Other | 2.6 | -0.1 | -0.2 | 7.7 | -1.0 | | | |
| Pre-tax income | 51.0 | 66.6 | -29.2 | 50.6 | -13.7 | 40.1 | 59.4 | 55.9 |
| Income taxes | 12.2 | 18.3 | -18.3 | 11.1 | -7.0 | 6.8 | 18.9 | 15.9 |
| Tax rate | 23.9% | 27.5% | 62.5% | 22.0% | 51.2% | 17.0% | 31.8% | 28.5% |
| Net income | 30.2 | 42.3 | -20.0 | 39.5 | -6.7 | 33.3 | 40.5 | 40.0 |
| Net margin | 8.4% | 11.6% | -5.7% | 10.8% | -2.6% | 9.8% | 11.1% | 12.3% |
| |
| Basic EPS [+] | $1.21 | $1.51 | ($0.35) | $1.26 | ($0.21) | $1.06 | $1.19 | $1.11 |
| Growth | -19.7% | -537.3% | -127.5% | -692.9% | -120.0% | -10.7% | 7.1% | 28.7% |
| Diluted EPS [+] | $1.18 | $1.48 | ($0.35) | $1.24 | ($0.21) | $1.04 | $1.16 | $1.08 |
| Growth | -20.0% | -527.5% | -127.9% | -683.9% | -120.4% | -10.1% | 6.6% | 28.0% |
| |
| Shares outstanding (basic) [+] | 31.9 | 31.9 | 31.7 | 31.4 | 31.4 | 31.4 | 34.2 | 36.1 |
| Growth | -0.1% | 0.7% | 0.9% | 0.0% | -0.2% | -8.0% | -5.3% | 1.1% |
| Shares outstanding (diluted) [+] | 32.8 | 32.7 | 31.7 | 31.9 | 31.4 | 32.1 | 35.1 | 36.9 |
| Growth | 0.3% | 3.0% | -0.6% | 1.6% | -2.1% | -8.6% | -4.8% | 1.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|